DNA vaccination against hepatitis C

Current Opinion in Molecular Therapeutics

Volumn 6, Issue 2, 2004, Pages 146-150

  Dueñas Carrera, Santiago ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

Adjuvant; Delivery; DNA immunization; Hepatitis C virus; Therapy; Vaccine

Indexed keywords

DNA VACCINE; HEPATITIS VACCINE; VIRUS ENVELOPE PROTEIN;

ANIMAL; DRUG DELIVERY SYSTEM; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; PLASMID; REVIEW; VACCINATION;

ANIMALS; DRUG DELIVERY SYSTEMS; HEPACIVIRUS; HEPATITIS C; HUMANS; PLASMIDS; VACCINATION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL HEPATITIS VACCINES;

EID: 7944220975     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Inchauspe G, Feinstone S: Development of a hepatitis C virus vaccine. Clin Liver Dis (2003) 7(1):243-259.
2. Nevens F, Roskams T, Van Vlierberghe H, Horsmans Y, Sprengers D, Elewaut A, Desmet V, Leroux-Roels G, Quinaux E, Depla E, Dincq S et al: A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C. Hepatology (2003) 38(5):1289-1296.
3. Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, Ghrayeb J, Murthy KK, Rice CM, Walker CM: HCV persistence and immune evasion in the absence of memory T cell help. Science (2003) 302(5645):659-662.
4. Ada G, Ramshaw I: DNA vaccination. Expert Opin Emerg Drugs (2003) 8(1):27-35.
5. Lowrie DB: DNA vaccination: An update. Methods Mol Med (2003) 87:377-390.
6. Murata K, Lechmann M, Qiao M, Gunji T, Alter HJ, Liang TJ: Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection. Proc Natl Acad Sci USA (2003) 100(11):6753-6758.
7. Dueñas-Carrera S, Vina A, Martinez R, Alvarez-Lajonchere L, Alvarez-Obregon JC, Marante J, Perez A, Mosqueda O, Martinez G, Morales J: Immunization with a DNA vaccine encoding the hepatitis C virus structural antigens elicits specific immune response against the capsid and envelope proteins in rabbits and macaques irus. Biotechnol Appl Biochem (2004): 39(2):249-255.
8. Pancholi P, Perkus M, Tricoche N, Liu Q, Prince AM: DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice. J Virol (2003) 77(1):382-390.
9. Isaguliants MG, Petrakova NV, Mokhonov VV, Pokrovskaya K, Suzdaltzeva YG, Krivonos AV, Zaberezhny AD, Garaev MM, Smirnov VD, Nordenfelt E: DNA immunization efficiently targets conserved functional domains of protease and ATPase/helicase of nonstructural 3 protein (NS3) of human hepatitis C virus. Immunol Lett (2003) 88(1):1-13.
10. Frelin L, Alheim M, Chen A, Soderholm J, Rozell B, Barnfield C, Liljestrom P, Sallberg M: Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo. Gene Ther (2003) 10(8):686-699.
11. Youn JW, Park SH, Cho JH, Sung YC: Optimal induction of T-cell responses against hepatitis C virus E2 by antigen engineering in DNA immunization. J Virol (2003) 77(21):11596-11602.
12. Simon BE, Cornell KA, Clark TR, Chou S, Rosen HR, Barry RA: DNA vaccination protects mice against challenge with Listeria monocytogenes expressing the hepatitis C virus NS3 protein. Infect Immun (2003) 71(11):6372-6380.
13. Xie Y, Tao Q, Gao J: Effects of HBV preS as a humoral enhancer on the abilities of HCV E2 protein to induce immune responses in the DNA-immunized mice. Chin Med Sci J (2003) 18(1):14-19.
14. Bu Z, Ye L, Skeen MJ, Ziegler HK, Compans RW, Yang C: Enhancement of immune responses to an HIV Env DNA vaccine by a C-terminal segment of listeriolysin O. AIDS Res Hum Retroviruses (2003) 19(5):409-420.
15. Delcayre A, Peake JS, White DJ, Yuan S, McDonald MK, Liang A, Tan PL, Watson JD: A genome-based functional screening approach to vaccine development that combines in vitro assays and DNA immunization. Vaccine (2003) 21(23):3259-3264.
16. Donnelly J, Berry K, Ulmer JB: Technical and regulatory hurdles for DNA vaccines. Int J Parasitol (2003) 33(5-6):457-467.
17. Jiao X, Wang RY, Feng Z, Alter HJ, Shih JW: Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization. Hepatology (2003) 37(2):452-460.
18. Ha SJ, Kim DJ, Baek KH, Yun YD, Sung YC: IL-23 induces stronger sustained CTL and Th1 immune responses than IL-12 in hepatitis C virus envelope protein 2 DNA immunization. J Immunol (2004) 172(1):525-531.
19. Lee S, Gierynska M, Eo SK, Kuklin N, Rouse BT: Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus. Microbes Infect (2003) 5(7):571-578.
20. Encke J, zu Putlitz J, Stremmel W, Wands JR: CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization. Arch Virol (2003) 148(3):435- 448.
21. Zhou X, Zheng L, Liu L, Xiang L, Yuan Z: T helper 2 immunity to hepatitis B surface antigen primed by gene-gun-mediated DNA vaccination can be shifted towards T helper 1 immunity by codelivery of CpG motifcontaining oligodeoxynucleotides. Scand J Immunol (2003) 58(3):350-357.
22. Mittenbuhler K, Esche Uvd, Heinevetter L, Bessler WG, Huber M: Lipopeptides: Adjuvanticity in conventional and genetic immunization. FEMS Immunol Med Microbiol (2003) 37(2-3):193-200.
23. Locher CP, Putnam D, Langer R, Witt SA, Ashlock BM, Levy JA: Enhancement of a human immunodeficiency virus Env DNA vaccine using a novel polycationic nanoparticle formulation. Immunol Lett (2003) 90(2-3):67-70.
24. Oh YK, Park JS, Kang MJ, Ko JJ, Kim JM, Kim CK: Enhanced adjuvanticity of interleukin-2 plasmid DNA administered in polyethylenimine complexes. Vaccine (2003) 21(21-22):2837-2843.
25. Sharpe S, Hanke T, Tinsley-Bown A, Dennis M, Dowall S, McMichael A, Cranage M: Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara. Virology (2003) 313(1):13-21.
26. Mumper RJ, Cui Z: Genetic immunization by jet injection of targeted pDNA-coated nanoparticles. Methods (2003) 31(3):255-262.
27. Raviprakash K, Ewing D, Simmons M, Porter KR, Jones TR, Hayes CG, Stout R, Murphy GS: Needle-free Biojector injection of a Dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys. Virology (2003) 315(2):345-352.
28. Matsui M, Moriya O, Akatsuka T: Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid. Vaccine (2003) 21(15):1629-1639.
29. Park SH, Yang SH, Lee CG, Youn JW, Chang J, Sung YC: Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost. Vaccine (2003) 21(31):4555- 4564.
30. Rollier C, Depla E, Drexhage JA, Verschoor EJ, Verstrepen BE, Fatmi A, Brinster C, Fournillier A, Whelan JA, Whelan M, Jacobs D et al: Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response. J Virol (2004) 78(1):187-196.